Inappropriate restriction of dietary gluten and associated bone acquisition and bone density in Egyptian children with coeliac disease

Archives of Medical Science

Volumn 5, Issue 4, 2009, Pages 589-595

  ElBaky, Abeer Abd ^a   Ismail, Nagwa ^a   Salama, Emad ^a   Abou Zekri, Maha ^b   Fatouh, Amany ^a   Ragab, Shadia ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Children; Coeliac disease; Gluten free diet; Osteoporosis

Indexed keywords

CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; DEOXYPYRIDINOLINE; GLUTEN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CELIAC DISEASE; CHILD; CLINICAL ARTICLE; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; EGYPT; FEMALE; FEMUR NECK; GLUTEN FREE DIET; HUMAN; LABORATORY; LUMBAR VERTEBRA; MALE; PHYSICIAN; PRACTICE GUIDELINE; URINALYSIS;

EID: 75349097520     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Hernandez L, Green PH. Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep 2006; 8: 383-9.
2. Żebrowska A, Waszczykowska E. Osteopenia and osteoporosis in patients with dermatitis herpetiformis. Effect of gluten-free diet. Arch Med Sci 2007; 3: 252-8.
3. Muzzo S, Burrows R, Burgueno M, et al. Effect of calcium and vitamin D supplementation on bone mineral density of celiac children. Nutrition Research 2000; 20: 1241-7.
4. McFarlane XA, Bhalla AK, Reeves DE, Morgan LM, Robertson DA. Osteoporosis in treated adult coeliac disease. Gut 1995; 36: 710-4.
5. de Rosa A, Troncone A, Vacca M, Ciacci C. Characteristics and quality of illness behavior in celiac disease. Psychosomatics 2004; 45: 336-42.
6. Neumann E. New pathophysological relevant metabolic pathways in osteoporosis. Future innovative therapies? Z Rheumatol 2006; 65: 400, 402-6.
7. Hartman C, Hochberg Z, Shamir R. Osteoporosis in pediatrics. Isr Med Assoc J 2003; 5: 509-15.
8. Rosen CJ, Tenenhouse A. Biochemical markers of bone turnover. A look at laboratory tests that reflect bone status. Postgrad Med 1998; 104: 101-2, 107-10, 113-4.
9. Fiore CE, Pennisi P, Ferro G, et al. Altered osteoprotegerin/RANKL ratio and low bone mineral density in celiac patients on long-term treatment with gluten-free diet. Horm Metab Res 2006; 38: 417-22.
10. Hill ID, Dirks MH, Liptak GS, et al; North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005; 40: 1-19.
11. Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322-8.
12. Mather KJ, Meddings JB, Beck P, et al. Prevalence of IgA antiendomysial antibody in asymptomatic low bone mineral density. Am J Gastroenterol 2001; 96: 120-5.
13. de Onis M, Onyango AW, Van den Broeck J, Chumlea WC, Martorell R. Measurement and standardization protocols for anthropometry used in the construction of a new international growth reference. Food Nutr Bull 2004; 25 (1 Suppl): S27-36.
14. nd ed. Blackwell scientific publication, Oxford 1962.
15. Knapen MH, Schurgers LJ, Vermeer C. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 2007; 18: 963-72.
16. Saggese G, Bertelloni S, Baroncelli GI, Di Nero G. Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1st year of life to adulthood and in metabolic bone diseases. Eur J Pediatr 1992; 151: 764-8.
17. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994; 9: 1643-9.
18. Kyrtsonis MC, Vassilakopoulos TP, Siakantaris MP, et al. Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease. Eur J Haematol 2004; 72: 252-8.
19. Avbersek-Luznik I, Balon BP, Rus I, Marc J. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? Nephrol Dial Transplant 2005; 20: 566-70.
20. Zanchetta JR, Plotkin H, Alvarez Filgueira ML. Bone mass in children: normative values for the 2-20-year-old population. Bone 1995; 16 (4 Suppl): 393S-9S.
21. Valdimarsson T, Toss G, Ross I, Löfman O, Ström M. Bone mineral density in coeliac disease. Scand J Gastroenterol 1994; 29: 457-61.
22. Vahedi K, Mascart F, Mary JY, et al. Reliability of antitransglutaminase antibodies as predictors of glutenfree diet compliance in adult celiac disease. Am J Gastroenterol 2003; 98: 1079-87.
23. Kumar PJ, Walker-Smith J, Milla P, Harris G, Colyer J, Halliday R. The teenage coeliac: follow up study of 102 patients. Arch Dis Child 1988; 63: 916-20.
24. Fabiani E, Taccari LM, Rätsch IM, Di Giuseppe S, Coppa GV, Catassi C. Compliance with gluten-free diet in adolescents with screening-detected celiac disease: a 5-year follow-up study. J Pediatr 2000; 136: 841-3.
25. Bardella MT, Molteni N, Prampolini L, et al. Need for follow up in coeliac disease. Arch Dis Child 1994; 70: 211-3.
26. Goddard CJ, Gillett HR. Complications of coeliac disease: are all patients at risk? Postgrad Med J 2006; 82: 705-12.
27. Kupper C. Dietary guidelines and implementation for celiac disease. Gastroenterology 2005; 128 (4 Suppl 1): S121-7.
28. Raymond N, Heap J, Case S. The Gluten-Free Diet: An Update for Health Professionals. Pract Gastroenterol 2006; 30: 67-92.
29. Kalayci AG, Kansu A, Girgin N, Kucuk O, Aras G. Bone mineral density and importance of a gluten-free diet in patients with celiac disease in childhood. Pediatrics 2001; 108: E89.
30. Barera G, Mora S, Brambilla P, et al. Body composition in children with celiac disease and the effects of a glutenfree diet: a prospective case-control study. Am J Clin Nutr 2000; 72: 71-5.
31. Tau C, Mautalen C, De Rosa S, Roca A, Valenzuela X. Bone mineral density in children with celiac disease. Effect of a Gluten-free diet. Eur J Clin Nutr 2006; 60: 358-63.
32. Lu PW, Briody JN, Ogle GD, et al. Bone mineral density of total body, spine, and femoral neck in children and young adults: a cross-sectional and longitudinal study. J Bone Miner Res 1994; 9: 1451-8.
33. Mora S, Barera G, Beccio S, et al. A prospective, longitudinal study of the long-term effect of treatment on bone density in children with celiac disease. J Pediatr 2001; 139: 516-21.
34. Sugai E, Cherñavsky A, Pedreira S, et al. Bone-specific antibodies in sera from patients with celiac disease: characterization and implications in osteoporosis. J Clin Immunol 2002; 22: 353-62.
35. Indridason OS, Franzson L, Sigurdsson G. Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover. Osteoporos Int 2005; 16: 417-23.
36. Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 2002; 20: 795-823.
37. Rogers A, Eastell R. Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 2005; 90: 6323-31.